At Close: Dec 08, 2023
Veradigm's (MDRX) New Offering to Enhance Patient Engagement01:32pm, Friday, 10'th Nov 2023
Veradigm's (MDRX) latest solution is likely to offer its clients the right payment option to each individual patient through the right communication channel.
Veradigm (MDRX)-FDB Vela to Enhance Pharmacy Connectivity12:02pm, Monday, 09'th Oct 2023
Veradigm's (MDRX) latest progress with FDB Vela is likely to offer prescribers and patients greater choice and cost transparency.
Veradigm (MDRX) Advances Tie-Up to Enhance Care Delivery02:16pm, Wednesday, 04'th Oct 2023
Veradigm's (MDRX) new phase of strategic investment is likely to drive innovation and close the evidence gap in behavioral health.
Veradigm's (MDRX) New Tie-Up to Boost Patients' Health Outcomes11:16am, Friday, 29'th Sep 2023
Veradigm's (MDRX) latest partnership is likely to promote value-based care initiatives for healthcare providers and the patients they serve.
Here's Why You Should Retain Veradigm (MDRX) Stock for Now01:41pm, Monday, 15'th May 2023
Veradigm (MDRX) continues to hold on to investors' interests owing to its strategic alliances.
3 Service Stocks Poised to Beat Earnings Estimates in Q409:47am, Wednesday, 22'nd Feb 2023
Here we pick three business service stocks, namely PagSeguro Digital (PAGS), Veradigm (MDRX) and TuSimple (TSP), which are likely to pull off earnings surprises this time around.
Will (MDRX) Beat Estimates Again in Its Next Earnings Report?01:33pm, Friday, 03'rd Feb 2023
(MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MDRX or VERI: Which Is the Better Value Stock Right Now?12:47pm, Wednesday, 01'st Feb 2023
MDRX vs. VERI: Which Stock Is the Better Value Option?
Strength Seen in Veradigm (MDRX): Can Its 5.0% Jump Turn into More Strength?09:02am, Thursday, 12'th Jan 2023
Veradigm (MDRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Here's Why You Should Retain Veradigm (MDRX) Stock for Now12:02pm, Tuesday, 10'th Jan 2023
Investors continue to be optimistic about Veradigm (MDRX) owing to its strategic alliances.
Veradigm to Present at the 2023 J.P. Morgan Healthcare Conference08:01am, Friday, 06'th Jan 2023
CHICAGO--( BUSINESS WIRE )--Veradigm Inc. (Nasdaq:MDRX), formerly Allscripts Healthcare Solutions Inc., announced today that Rick Poulton, Veradigm Chief Executive Officer, will present at the 2023 J.
3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio12:02pm, Wednesday, 07'th Dec 2022
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
Allscripts Healthcare Solutions: The Picture Is Improving12:17pm, Tuesday, 22'nd Nov 2022
Allscripts Healthcare Solutions has done well to post sales and cash flow growth in recent quarters. The company still faces uncertainty and risks moving forward, but it's healthy and trading on the c
Allscripts Healthcare Solutions, Inc. (MDRX) Q3 2022 Earnings Call Transcript04:59pm, Saturday, 05'th Nov 2022
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Jenny Gelinas - VP, IR Richard Poulton - CEO Thomas Langan - Pres